标题
Targeting transcription factors
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 6, Pages 652-658
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-09-18
DOI
10.1097/01.cco.0000432528.88101.1a
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation
- (2015) Erik A. Nelson et al. Oncotarget
- Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer
- (2013) Giovanni Roti et al. CANCER CELL
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
- (2013) T. A. Mace et al. CANCER RESEARCH
- PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
- (2013) S. Picaud et al. CANCER RESEARCH
- miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
- (2013) Jun Wei et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment
- (2013) Xin Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo
- (2013) Di Yin et al. NANOTECHNOLOGY
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stapled Peptides with Improved Potency and Specificity That Activate p53
- (2012) Christopher J. Brown et al. ACS Chemical Biology
- Molecular docking and synthesis of novel quinazoline analogues as inhibitors of transcription factors NF-κB activation and their anti-cancer activities
- (2012) Lu Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A “Twist box” Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation
- (2012) Sara Piccinin et al. CANCER CELL
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
- (2012) Jiehui Deng et al. CANCER CELL
- Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
- (2012) Jie Liang et al. CANCER CELL
- Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma
- (2012) X Wang et al. CANCER GENE THERAPY
- Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma
- (2012) Huijie Jia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer
- (2012) Jong-Lyel Roh et al. CANCER LETTERS
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
- (2012) Massimo Zollo et al. CLINICAL & EXPERIMENTAL METASTASIS
- PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
- (2012) Wu-Chou Su et al. International Journal of Nanomedicine
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
- (2012) Uciane K. Scarlett et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Ultrahigh Affinity d-Peptide Antagonist Of MDM2
- (2012) Changyou Zhan et al. JOURNAL OF MEDICINAL CHEMISTRY
- A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
- (2012) Inès Souissi et al. Molecular Cancer
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
- (2012) Marka R. Crittenden et al. PLoS One
- Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide
- (2012) J. A. Raskatov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
- (2012) Dinja Oosterhoff et al. OncoImmunology
- Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis
- (2011) Alessandro Ble et al. AMERICAN JOURNAL OF NEPHROLOGY
- Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo
- (2011) Zuo-Wen Liang et al. ASIAN JOURNAL OF ANDROLOGY
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Seeing the Future of Cancer-Associated Transcription Factor Drug Targets
- (2011) Panagiotis A. Konstantinopoulos JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protection From Arthritis and Myositis in a Mouse Model of Acute Chikungunya Virus Disease by Bindarit, an Inhibitor of Monocyte Chemotactic Protein-1 Synthesis
- (2011) Nestor E. Rulli et al. JOURNAL OF INFECTIOUS DISEASES
- Modulation of NF- B-dependent gene transcription using programmable DNA minor groove binders
- (2011) J. A. Raskatov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
- (2010) Miguel Aste-Amézaga et al. PLoS One
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
- (2009) Lin Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis
- (2008) M. Bhatia et al. INFLAMMATION RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started